Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 3—March 2011
Synopsis

Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia

Sami SimonsComments to Author , Jakko van Ingen, Po-Ren Hsueh, Nguyen Van Hung, P.N. Richard Dekhuijzen, Martin J. Boeree, and Dick van Soolingen
Author affiliations: Author affiliations: Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (S. Simons, J. van Ingen, P.N.R. Dekhuijzen, M.J. Boeree); National Institute for Public Health and the Environment (RIVM),; Bilthoven, the Netherlands (J. van Ingen, D. van Soolingen); National Taiwan University Hospital, Taipei, Taiwan (P.-R. Hsueh); National Hospital of Tuberculosis and Respiratory Diseases, Hanoi, Vietnam (N.V. Hung)

Main Article

Table 2

Clinical relevance of NTM species isolated from pulmonary samples collected in Asia, by country, 1971–2007*

Study area No. patients Patients for whom NTM infection was considered clinically relevant, % Criteria used (year of revision) Reference
Hong Kong 168 17 ATS criteria (1990) (6)
Japan 357 76† ATS criteria (1997) (16)
South Korea 794 17 ATS criteria (1997) (21)
South Korea 23 65‡ BTS criteria (1999) (23)
Singapore 23 65 Compatible signs and symptoms, >3 positive sputum specimens, and radiographic features of recent lung disease (25)
Taiwan 111 9 ATS criteria (1990) (28)
Taiwan 169 28§ NTM in >2 samples, new radiographic lesions ,and no other pathogens (definite) or other concomitant bacteria (probable NTM) found (29)
Thailand 33 76 NTM in sample(s); compatible signs, symptoms, and radiographic features; and no other explanation (30)
Thailand 24 29 Continued NTM isolation, progressive pulmonary disease, and worsening radiographic lesions (32)
Thailand 42 71 Repeated isolation of high numbers of NTM and presence of compatible disease process (33)

*NTM, nontuberculous mycobacterium; ATS, American Thoracic Society (1); BTS, British Thoracic Society.
†Only Mycobacterium avium complex bacteria were included in this study.
‡Only M. kansasii was included.
§14% if only definite NTM were included.

Main Article

References
  1. Griffith  DE, Aksamit  T, Brown-Elliot  BA, Catanzaro  A, Daley  C, Gordin  F, An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. DOIPubMedGoogle Scholar
  2. van Ingen  J, Bendien  SA, de Lange  WC, Hoefsloot  W, Dekhuijzen  PN, Boeree  MJ, Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, the Netherlands. Thorax. 2009;64:502–6. DOIPubMedGoogle Scholar
  3. Marras  TK, Daley  C. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23:553–67. DOIPubMedGoogle Scholar
  4. Tsukamura  M, Shimoide  H, Kita  N, Kawakami  K, Ito  T, Nakajima  N, Epidemiologic studies of lung disease due to mycobacteria other than Mycobacterium tuberculosis in Japan. Rev Infect Dis. 1981;3:997–1007. DOIPubMedGoogle Scholar
  5. Weimin  L, Guanglu  J, Zhihui  L, Huakan  H, Liquan  C, Miao  T, Non-tuberculous mycobacteria in China. Scand J Infect Dis. 2007;39:138–41. DOIPubMedGoogle Scholar
  6. Hosker  HSR, Lam  CW, Ng  TK, Ma  HK, Chan  SL. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med. 1995;89:3–8. DOIPubMedGoogle Scholar
  7. Agarwal  SK, Jamil  Z, Srivasta  VK, Rathi  AK, Mehrotra  L. A clinico-bacteriological assessment of pulmonary tuberculosis patients with reference to drug resistance pattern in treated and untreated cases. Indian J Med Sci. 1980;34:39–46.PubMedGoogle Scholar
  8. Choudri  DS, Dube  MK, Purohit  SD, Dube  S. The prevalence of anonymous mycobacteria in both resistant as well as fresh cases of pulmonary tuberculosis in the local population of south east Rajasthan. [PMID: 114478]. Indian J Pathol Microbiol. 1979;22:165–75.
  9. Jesudason  MV, Gladstone  P. Non tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital in south India. Indian J Med Microbiol. 2005;23:172–5. DOIPubMedGoogle Scholar
  10. Karak  K, Bhattacharyya  S, Majumdar  S, De  PK. Pulmonary infection caused by mycobacteria other than M. tuberculosis in and around Calcutta. Indian J Pathol Microbiol. 1996;39:131–4.PubMedGoogle Scholar
  11. Paramasivan  CN, Govindan  D, Prabhakar  R, Somasundaram  PR, Subbammal  S, Tripathy  SP. Species level identification of non-tuberculous mycobacteria from south Indian BCG trial area during 1981. Tubercle. 1985;66:9–15. DOIPubMedGoogle Scholar
  12. Ramakrishnan  CV. Pulmonary disease due to atypical mycobacteria: a retrospective study from south India. Rev Infect Dis. 1981;3:1090–2. DOIPubMedGoogle Scholar
  13. Shanker  SVR, Jain  NK, Chandrasekhar  S, Singh  MM. Prevalence of atypical mycobacteria in sputum of patients undergoing treatment at a tuberculosis clinic. Indian J Chest Dis Allied Sci. 1989;31:9–13.PubMedGoogle Scholar
  14. Kobashi  Y, Matsushima  T. Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines. J Infect Chemother. 2004;10:25–30. DOIPubMedGoogle Scholar
  15. Kobashi  Y, Matsushima  T. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan—including a follow-up study. Respiration. 2007;74:394–400. DOIPubMedGoogle Scholar
  16. Okumura  M, Iwai  K, Ogata  H, Ueyama  M, Kubota  M, Aoki  M, Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med. 2008;47:1465–72. DOIPubMedGoogle Scholar
  17. Saito  H, Watanabe  T, Akamatsu  S, Yamamoto  Y, Irikura  T, Kubonishi  K, Incidence of atypical mycobacteria and pulmonary mycobacterioses in national sanatoria in the Chugoku-Shikoku area. Hiroshima J Med Sci. 1979;28:161–5.PubMedGoogle Scholar
  18. Rapid increase of the incidence of lung disease due to Mycobacterium kansasii in Japan. Chest. 1983;83:890–2. DOIPubMedGoogle Scholar
  19. Tsukamura  M, Kita  N, Shimoide  H, Arakawa  H, Kuze  A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis. 1988;137:1280–4.PubMedGoogle Scholar
  20. Yamamoto  M. Pulmonary disease due to Mycobacterium szulgai in Japan. Intern Med. 2000;39:277–9. DOIPubMedGoogle Scholar
  21. Koh  WJ, Kwon  OJ, Jeon  K, Kim  TS, Lee  KS, Park  YK, Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006;129:341–8. DOIPubMedGoogle Scholar
  22. Ryoo  SW, Shin  S, Shim  MS, Park  YS, Lew  WJ, Park  SN, Spread of nontuberculous mycobacteria from 1992 to 2006 in Koreans. J Clin Lab Anal. 2008;22:415–20. DOIPubMedGoogle Scholar
  23. Yim  JJ, Park  YK, Lew  WJ, Bai  GH, Han  SK, Shim  YS. Mycobacterium kansasii pulmonary disease in Korea. J Korean Med Sci. 2005;20:957–60. DOIPubMedGoogle Scholar
  24. Yim  JJ, Kim  HJ, Kwon  OJ, Koh  WJ. Association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and nontuberculous mycobacterial lung disease in a Korean population. Hum Immunol. 2008;69:572–6. DOIPubMedGoogle Scholar
  25. Teo  SK, Lo  KL. Nontuberculous mycobacterial disease of the lungs in Singapore. Singapore Med J. 1992;33:464–6.PubMedGoogle Scholar
  26. Chien  HP, Yu  MC. WU MH, Lin TP, Luh KT. Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis. 2000;4:866–70.PubMedGoogle Scholar
  27. Ding  LW, Lai  CC, Lee  LN, Hsueh  PR. Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997–2003. Epidemiol Infect. 2006;134:1060–7. DOIPubMedGoogle Scholar
  28. Shih  JY, Hsueh  PR, Lee  LN, Wang  HC, Yang  PC, Kuo  SH, Nontuberculous mycobacteria isolates: clinical significance and disease spectrum. J Formos Med Assoc. 1997;96:621–7.PubMedGoogle Scholar
  29. Shu  CC, Lee  CH, Wang  JY, Jerng  JS, Yu  CJ, Hsueh  PR, Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med. 2008;34:2194–201. DOIPubMedGoogle Scholar
  30. Ratanasuwan  W, Techasathit  W, Chuenarom  V, Suwanagool  S, Anekthananont  T, Jearanaisilavong  J, Infection due to nontuberculous Mycobacterium other than MAC in AIDS patients at Siriraj Hospital during 1998–2000: saphophyte vs pathogen. J Med Assoc Thai. 2002;85:886–93.PubMedGoogle Scholar
  31. Saritsiri  S, Udomsantisook  N, Suankratay  C. Nontuberculous infections in King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2006;89:2035–46.PubMedGoogle Scholar
  32. Sriyabhaya  N, Wongwatana  S. Pulmonary infection caused by atypical mycobacteria: a report of 24 cases in Thailand. Rev Infect Dis. 1981;3:1085–9. DOIPubMedGoogle Scholar
  33. Wongwatana  S, Sriyabhaya  N. Nontuberculous mycobacterial infection of the lung in a chest hospital in Thailand. J Med Assoc Thai. 1992;75:1–10.PubMedGoogle Scholar
  34. van Ingen  J, Boeree  MJ, Kösters  K, Wieland  A, Tortoli  E, Dekhuijzen  PN, Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov. Int J Syst Evol Microbiol. 2009;59:2277–82. DOIPubMedGoogle Scholar
  35. Ben Salah  I, Cayrou  C, Raoult  D, Drancourt  M. Mycobacterium marseillense sp. nov., Mycobacterium timonense sp. nov., and Mycobacterium bouchedurhonense sp. nov., members of the Mycobacterium avium complex. Int J Syst Evol Microbiol. 2009;59:2803–8. DOIPubMedGoogle Scholar
  36. O’Brien  RJ, Geiter  LJ, Snider  D. The epidemiology of nontuberculous mycobacterial diseased in the United States. Am Rev Respir Dis. 1987;135:1007–14.PubMedGoogle Scholar
  37. Trnka  L, Dankova  D, Svandova  E. Six years’ experience with the discontinuation of BCG vaccination: 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. [ PMID: 7841428]. Tuber Lung Dis. 1994;75:348–52. DOIPubMedGoogle Scholar
  38. Buijtels  PC, Petit  PL. Comparison of NaOH-n-acetyl cysteine and sulfuric acid decontamination methods for recovery of mycobacteria from clinical specimens. J Microbiol Methods. 2005;62:83–8. DOIPubMedGoogle Scholar
  39. Adékambi  T, Colson  P, Drancourt  M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol. 2003;41:5699–708. DOIPubMedGoogle Scholar
  40. Tortoli  E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev. 2003;16:319–54. DOIPubMedGoogle Scholar

Main Article

Page created: July 25, 2011
Page updated: July 25, 2011
Page reviewed: July 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external